NOTES
2. Segment information
| Q2 2026 | Q2 2025 | |||||||
|---|---|---|---|---|---|---|---|---|
| EUR million | Healthcare Services | Diagnostic Services | Central/other | Group Total | Healthcare Services | Diagnostic Services | Central/other | Group Total |
| Revenue | 442.8 | 205.1 | 0.4 | 414.3 | 189.0 | 0.2 | ||
| Inter-segment revenue | -0.6 | -7.3 | 0.0 | -0.5 | -6.2 | -0.1 | ||
| Revenue from external customers | 442.2 | 197.8 | 0.4 | 640.4 | 413.8 | 182.8 | 0.1 | 596.7 |
| By payer: | ||||||||
| Private | 369.4 | 141.7 | 0.4 | 511.5 | 342.8 | 125.6 | 0.1 | 468.5 |
| Public | 72.8 | 56.1 | 0.0 | 128.9 | 71.0 | 57.2 | 0.0 | 128.2 |
| By country: | ||||||||
| Poland | 314.5 | 23.2 | 0.0 | 337.7 | 285.0 | 21.6 | 0.0 | 306.6 |
| Germany | 11.8 | 85.2 | - | 97.0 | 14.3 | 79.9 | - | 94.2 |
| Romania | 48.5 | 35.8 | - | 84.3 | 46.8 | 33.9 | - | 80.7 |
| India | 60.8 | - | 0.1 | 60.9 | 49.4 | - | 0.0 | 49.4 |
| Ukraine | 2.6 | 24.8 | - | 27.4 | 2.0 | 20.7 | - | 22.7 |
| Other countries | 4.0 | 28.8 | 0.3 | 33.1 | 16.3 | 26.7 | 0.1 | 43.1 |
| Operating profit | 41.9 | 23.3 | -14.0 | 51.2 | 38.3 | 18.8 | -15.4 | 41.7 |
| Margin | 9.5% | 11.4% | 8.0% | 9.3% | 10.0% | 7.0% | ||
| Depreciation, amortisation and impairment | 39.4 | 15.3 | 0.9 | 55.6 | 38.9 | 14.7 | 0.9 | 54.5 |
| EBITDA | 81.3 | 38.6 | -13.1 | 106.8 | 77.2 | 33.5 | -14.5 | 96.2 |
| Margin | 18.4% | 18.8% | 16.7% | 18.6% | 17.7% | 16.1% | ||
| Right-of-use depreciation/impairment | -18.3 | -7.0 | -0.1 | -25.4 | -17.2 | -6.6 | -0.1 | -23.9 |
| Interest on lease liabilities | -7.4 | -1.3 | 0.0 | -8.7 | -6.5 | -1.3 | 0.0 | -7.8 |
| Segment result: EBITDAaL | 55.6 | 30.3 | -13.2 | 72.7 | 53.5 | 25.6 | -14.6 | 64.5 |
| Margin | 12.6% | 14.7% | 11.3% | 12.9% | 13.6% | 10.8% | ||
| Other income/(costs) | -0.1 | 1.6 | ||||||
| Net interest expense | -15.3 | -15.5 | ||||||
| Other financial income/(expense) | -2.6 | -3.0 | ||||||
| Share of profit of associates | 0.0 | 0.2 | ||||||
| Income tax | -9.3 | -7.0 | ||||||
| Profit for period | 23.9 | 18.0 | ||||||
| 6M 2026 | 6M 2025 | |||||||
|---|---|---|---|---|---|---|---|---|
| EUR million | Healthcare Services | Diagnostic Services | Central/other | Group Total | Healthcare Services | Diagnostic Services | Central/other | Group Total |
| Revenue | 874.5 | 405.4 | 0.8 | 816.9 | 371.2 | 0.3 | ||
| Inter-segment revenue | -1.3 | -14.5 | -0.3 | -1.0 | -12.5 | -0.1 | ||
| Revenue from external customers | 873.2 | 390.9 | 0.5 | 1,264.6 | 815.9 | 358.7 | 0.2 | 1,174.8 |
| By payer: | ||||||||
| Private | 729.3 | 279.4 | 0.5 | 1,009.2 | 675.5 | 246.4 | 0.2 | 922.1 |
| Public | 143.9 | 111.5 | 0.0 | 255.4 | 140.4 | 112.3 | 0.0 | 252.7 |
| By country: | ||||||||
| Poland | 623.8 | 45.4 | 0,0 | 669.2 | 560.2 | 43.7 | 0.1 | 604.0 |
| Germany | 24.0 | 170.2 | - | 194.2 | 29.4 | 163.1 | - | 192.5 |
| Romania | 98.0 | 71.9 | - | 169.9 | 91.9 | 65.3 | - | 157.2 |
| India | 115.1 | - | 0.1 | 115.2 | 96.9 | - | 0.0 | 96.9 |
| Ukraine | 4.6 | 46.6 | - | 51.2 | 4.4 | 41.7 | - | 46.1 |
| Other countries | 7.7 | 56.8 | 0.4 | 64.9 | 33.1 | 44.9 | 0.1 | 78.1 |
| Operating profit | 77.5 | 50.1 | -29.7 | 97.9 | 65.3 | 40.8 | -28.4 | 77.7 |
| Margin | 8.9% | 12.4% | 7.7% | 8.0% | 11.0% | 6.6% | ||
| Depreciation, amortisation and impairment | 78.1 | 30.2 | 1.8 | 110.1 | 74.8 | 28.6 | 1.6 | 105.0 |
| EBITDA | 155.6 | 80.3 | -27.9 | 208.0 | 140.1 | 69.4 | -26.8 | 182.7 |
| Margin | 17.8% | 19.8% | 16.5% | 17.2% | 18.7% | 15.6% | ||
| Right-of-use depreciation/impairment | -36.4 | -13.9 | -0.2 | -50.5 | -33.6 | -12.6 | -0.2 | -46.4 |
| Interest on lease liabilities | -14.7 | -2.7 | 0.0 | -17.4 | -13.0 | -2.5 | 0.0 | -15.5 |
| Segment result: EBITDAaL | 104.5 | 63.7 | -28.1 | 140.1 | 93.5 | 54.3 | -27.0 | 120.8 |
| Margin | 12.0% | 15.7% | 11.1% | 11.4% | 14.6% | 10.3% | ||
| Other income/(costs) | -0.1 | 1.8 | ||||||
| Net interest expense | -30.9 | -29.7 | ||||||
| Other financial income/(expense) | -5.1 | 1.1 | ||||||
| Share of profit of associates | 0.0 | 0.2 | ||||||
| Income tax | -17.3 | -14.3 | ||||||
| Profit for period | 44.5 | 36.8 | ||||||
| LTM | FY 2025 | |||||||
|---|---|---|---|---|---|---|---|---|
| EUR million | Healthcare Services | Diagnostic Services | Central/other | Group Total | Healthcare Services | Diagnostic Services | Central/other | Group Total |
| Revenue | 1,707.8 | 789.1 | 1.2 | 1,650.2 | 754.9 | 0.7 | ||
| Inter-segment revenue | -2.4 | -27.2 | -0.6 | -2.1 | -25.2 | -0.4 | ||
| Revenue from external customers | 1,705.4 | 761.9 | 0.6 | 2,467.9 | 1,648.1 | 729.7 | 0.3 | 2,378.1 |
| By payer: | ||||||||
| Private | 1,420.6 | 540.3 | 0.6 | 1,961.5 | 1,366.8 | 507.3 | 0.3 | 1,874.4 |
| Public | 284.8 | 221.6 | 0.0 | 506.4 | 281.3 | 222.4 | 0.0 | 503.7 |
| By country: | ||||||||
| Poland | 1,216.6 | 88.9 | 0.0 | 1,305.5 | 1,153.0 | 87.2 | 0.1 | 1,240.3 |
| Germany | 51.7 | 332.0 | - | 383.7 | 57.1 | 324.9 | - | 382.0 |
| Romania | 192.1 | 140.2 | - | 332.3 | 186.0 | 133.6 | - | 319.6 |
| India | 221.7 | - | 0.2 | 221.9 | 203.5 | - | 0.1 | 203.6 |
| Ukraine | 9.0 | 90.2 | 0.0 | 99.2 | 8.8 | 85.3 | - | 94.1 |
| Other countries | 14.3 | 110.6 | 0.4 | 125.3 | 39.7 | 98.7 | 0.1 | 138.5 |
| Operating profit | 146.7 | 88.8 | -59.6 | 175.9 | 134.5 | 79.5 | -58.3 | 155.7 |
| Margin | 8.6% | 11.2% | 7.1% | 8.1% | 10.5% | 6.5% | ||
| Depreciation, amortisation and impairment | 156.4 | 60.6 | 3.4 | 220.4 | 153.1 | 59.0 | 3.2 | 215.3 |
| EBITDA | 303.1 | 149.4 | -56.2 | 396.3 | 287.6 | 138.5 | -55.1 | 371.0 |
| Margin | 17.7% | 18.9% | 16.1% | 17.4% | 18.3% | 15.6% | ||
| Right-of-use depreciation/impairment | -72.0 | -27.8 | -0.3 | -100.1 | -69.2 | -26.5 | -0.3 | -96.0 |
| Interest on lease liabilities | -28.4 | -5.4 | 0.0 | -33.8 | -26.7 | -5.2 | 0.0 | -31.9 |
| Segment result: EBITDAaL | 202.7 | 116.2 | -56.5 | 262.4 | 191.7 | 106.8 | -55.4 | 243.1 |
| Margin | 11.9% | 14.7% | 10.6% | 11.6% | 14.1% | 10.2% | ||
| Other income/(costs) | -0.3 | 1.6 | ||||||
| Net interest expense | -60.9 | -59.7 | ||||||
| Other financial income/(expense) | -5.5 | 0.7 | ||||||
| Share of profit of associates | -0.1 | 0.1 | ||||||
| Income tax | -28.7 | -25.7 | ||||||
| Profit for period | 80.4 | 72.7 | ||||||